While the diagnostic value of cerebrospinal fluid (CSF) IL-10 and IL-10/IL-6 ratios has been established in primary CNS lymphoma (PCNSL) (12–15), their utility in predicting CNS relapse in SCNSL remains underexplored. The gene discussed is IL6; the disease is primary central nervous system lymphoma.